Logo

Swift Biosciences Normalase Amplicon SARS-CoV-2 S Gene Panel

Feb 03, 2021

Swift Biosciences has released the Normalase Amplicon SARS-CoV-2 S Gene Panel (SNAP), a targeted gene panel that covers 100 percent of the SARS-CoV-2 S gene even with limited viral titers. The new panel eliminates the need to perform qPCR for library normalization for downstream sequencing, Swift said.

Breaking News
The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.